Skip to main content

RT @DrTrishHarkins: ⚡️PNEUMOVAS⚡️ 💉reinforced anti pneumococcal vaccine in AAV pts on Rituximab💉 👉Rei

Social Author Name
Patricia Harkins
Tweet Content
⚡️PNEUMOVAS⚡️ 💉reinforced anti pneumococcal vaccine in AAV pts on Rituximab💉 👉Reinforced regimen (double dose PCV13 D0/D7 wt PPV23 @ M5) - sig ⬆️ Ab response 2 strep pneum ❓application 2 👉other vaccines 👉 other RTX tx IMRD #ACR22 AbstL16 @RheumNow @TerrierBen https://t.co/BnZWAoHDj6

RT @RichardPAConway: Maksymowych et al. RCT ofAdalimumab for knee OA!? it doesn't work. @RheumNow #ACR22 Abstr#1891 http

Social Author Name
Richard Conway
Tweet Content
Maksymowych et al. RCT ofAdalimumab for knee OA!? it doesn't work. @RheumNow #ACR22 Abstr#1891 https://t.co/pfPVJ9A1Ex https://t.co/X7sLEaqGvT

RT @Janetbirdope: What’s new w #classification for #APS? You don’t have to have 2 positive tests disseminated in tim

Social Author Name
Janet Pope
Tweet Content
What’s new w #classification for #APS? You don’t have to have 2 positive tests disseminated in time. BUT remember the the labs for anticardiolipin are shockingly variable btwn centres. @RheumNow #ACR22 https://t.co/NTqQ6h7fws

RT @DrCassySims: Abstract #PP25 Patient mantra on life with SpA: “not to over-exert the body on your good days and a

Social Author Name
Catherine Sims, MD
Tweet Content
Abstract #PP25 Patient mantra on life with SpA: “not to over-exert the body on your good days and always strive to be active on your bad days” Patient recommended exercise: 🏓table tennis 🏊‍♂️swimming 🧘yoga 🤸tai chi #ACR22 @RheumNow

RT @KDAO2011: Staggering stats after a #osteoporosis hip fracture! 40% cannot walk independently 30% have a permanent d

Social Author Name
TheDaoIndex
Tweet Content
Staggering stats after a #osteoporosis hip fracture! 40% cannot walk independently 30% have a permanent disability 20% mortality in surgically fixed hip 40% mortality if not surgically fixed. -Dr. M Humphrey #ACR22 @rheumnow https://t.co/DSYQjDw6pW

RT @RichardPAConway: Morales et al. AUR200, novel BAFF/APRIL inhibitor. Looking promising in pre-clinical and animal mod

Social Author Name
Richard Conway
Tweet Content
Morales et al. AUR200, novel BAFF/APRIL inhibitor. Looking promising in pre-clinical and animal models. We will wait and see! @RheumNow #ACR22 Abstr#1629 https://t.co/htmX2GHV3X https://t.co/jvhFdx2c52

RT @RichardPAConway: Lin et al. Genetic risk (HR 2.3 women, 2.63 men) and lifestyle (HR 5.7 for women, 3.7 for men) both

Social Author Name
Richard Conway
Tweet Content
Lin et al. Genetic risk (HR 2.3 women, 2.63 men) and lifestyle (HR 5.7 for women, 3.7 for men) both individual contributors and synergistic (HR 9.1 women, 8.7 men) in gout development in both men and women. Modifiable! @RheumNow #ACR22 Abstr#1633 https://t.co/51KPgfXn1w https://t.co/gOU7DfOKvt
Subscribe to
×